Data / Research funding / University of Melbourne
University of Melbourne: 12 NIH awards ($49.1M), fiscal years 2021 to 2026
University of Melbourne in Melbourne is funded under 12 NIH awards ($49.1M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- P8JJC89CWNK5UEI
Awards
12 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | NIH | National Institute of Mental Health | 2021 to 2025 | $24,090,655 | September 8, 2020 | May 31, 2026 | NELSON, CHRISTOPHER BARNABY | reporter.nih.gov |
| Colon Cancer Family Registry Cohort | NIH | National Cancer Institute | 2021 to 2025 | $8,978,119 | May 1, 2013 | April 30, 2028 | JENKINS, MARK A | reporter.nih.gov |
| Alzheimer's dementia onset and progression in international cohorts (Amended) | NIH | National Institute on Aging | 2021 to 2022 | $4,403,042 | September 30, 2018 | May 31, 2025 | MASTERS, COLIN | reporter.nih.gov |
| Does repeated influenza vaccination constrain influenza immune responses and protection? | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,405,849 | July 3, 2019 | June 30, 2025 | FOX, ANNETTE | reporter.nih.gov |
| Investigating the basis of MAIT cell antigen potency | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,157,980 | June 15, 2020 | May 31, 2025 | MCCLUSKEY, JAMES | reporter.nih.gov |
| Building a multi-scale vascular atlas of the mouse lower urinary tract | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,581,853 | September 30, 2021 | July 31, 2027 | KEAST, JANET R | reporter.nih.gov |
| Understanding functional connectivity of sensory and motor pathways to specific regions of the lower urinary tract. | NIH | Office of the Director, National Institutes of Health | 2021 | $1,474,654 | September 28, 2016 | July 31, 2024 | KEAST, JANET R | reporter.nih.gov |
| Characterizing the evolution of impaired hypoglycemia awareness in people with type 1 diabetes and the impact of automated insulin delivery and exercise on restoring hypoglycemia awareness | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,196,456 | September 25, 2022 | December 31, 2027 | O'NEAL, DAVID NORMAN | reporter.nih.gov |
| The Evaluation of Two Response Thresholds to Continuous Ketone Monitoring Information Minimising Ketosis in People with Type 1 Diabetes Treated with Sotagliflozin. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $987,196 | September 12, 2025 | August 31, 2027 | O'NEAL, DAVID NORMAN | reporter.nih.gov |
| An integrated platform for studying sensory networks in the vertebrate brain | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $747,475 | September 15, 2020 | August 31, 2025 | SCOTT, ETHAN KIME | reporter.nih.gov |
| REINVIGORATE: Repeated Enhanced INfluenza Vaccines In Geriatrics of a Randomised trial for Antibody and T cell Effects | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $711,626 | April 11, 2024 | March 31, 2029 | DOAK, SOPHIE ALESSANDRA VALKENBURG | reporter.nih.gov |
| Direct and Indirect Targeting of HIV Tat for Selective RNA Degradation and Protein Suppression | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $394,820 | September 12, 2025 | August 31, 2030 | TELWATTE, SUSHAMA | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 7 | $7,719,308 | 0 | $0 |
| 2024 | 7 | $9,363,343 | 0 | $0 |
| 2023 | 5 | $3,181,222 | 0 | $0 |
| 2022 | 7 | $13,842,064 | 0 | $0 |
| 2021 | 7 | $15,023,788 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 4 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 4 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 4 awards here |
Topics of its NIH awards
- Clinical Research
- Prevention
- Neurosciences
- Infectious Diseases
- Translational Research
- Genetics
- Clinical Trials and Supportive Activities
- Aging
- Brain Disorders
- Biodefense and Related Countermeasures
- Emerging Infectious Diseases
- Immunization
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.